About me
- Director, Bipolar Disorders Unit
- Emeritus Associate Professor CE of Psychiatry
Education and training
- Medical School: Semmelweis Oorvostudomanyi Egyetem
- Residency: Mercy Fitzgerald Hospital
- Residency: Hospital of the University of Pennsylvania
My Locations
Penn Psychiatry Market Street
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
Qualifications and experience
- Psychiatry, 1991
- Abbott Laboratories, Glaxo-Wellcome, Bristol-Meyers-Squibb,
- American Psychiatric Association,
- American Suicide Foundation,
- Data Monitoring Board for "Reducing the Efficacy-Effectiveness Gap in Bipolar Disorder" (P.I.: Dr. Mark S. Bauer),
- Department of Veterans Affairs, Washington D.C.,
- Institutional Development Grant Program, North Carolina Biotechnology Center,
- Society of Nuclear Medicine,
- Special Programs, Office of Vocational Rehabilitation, Commonwealth of Pennsylvania,
My research
Gyulai, L., Bauer M., Bauer, M.S., Espana-Garcia, F, Whybrow, P.C. Lithium challenge to the thyroid axis in rapid cycling bipolar affective disorder and healthy controls , Biological Psychiatry, 53: 2003,899-905
Gyulai L. Bowden CL. McElroy SL. Calabrese JR. Petty F. Swann AC. Chou JC. Wassef A. Risch CS. Hirschfeld RM. Nemeroff CB. Keck PE Jr. Evans DL. Wozniak PJ. Maintenance efficacy of divalproex in the prevention of bipolar depression , Neuropsychopharmacology, 28: 2003,374-82
Gyulai, L., Bauer, M., Garcia-Espana, F., Hierholzer, J., Baumgartner, A., Whybrow, P.C. Supressive doses of thyroxine and bone mineral density in pre- and postmenopasual women with affective disorder , J. of Affective Disorders , 66: 2001,185-191
Nemeroff, C., Evans, D., Gyulai, L., Sachs, G., Bowden, C., Young, M., Pitts, C., Oaks, R., Gergel, I. A Double-Blind, Placebo-Controlled comparison of imipramine and paroxetine in the treatment of bipolar depression , American Journal of Psychiatry , 158: 2001,906-912
Cory Newman, Noreen Reilly-Harrington, Laszlo Gyulai, Aaron T. Beck Cognitive Therapy of Bipolar Disorder , : 2001
Bowden, C. H., Calabrese, J., McElroy, S., Gyulai, L., Wassef, A., Petty, F., Pope, HG., Chou C-Y., Keck, P., Rhodes, L., Swann, A., Hirschfeld, RM., Wozniak, P. Randomized, Placebo-Controlled Trial of Divalproex Versus Lithium in Maintenance Therapy of Bipolar Disorder , Arch. Gen. Psychiatry, 57: 2000,481-489
Sachs GS. Printz DJ. Kahn DA. Carpenter D. Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 , Postgraduate Medicine: 2000,1-104
Bauer, M, Berghoefer, A, Baumgartner, A, Gyulai, L, Whybrow, P.C. T4 Enhancement in Bipolar and Unipolar Illness , Neuropsychopharmacology, 23: 2000,S68
Hahn, C., Pawlyk A.C., Whybrow, P.C., Gyulai, L., Tejani-Butt, S.M. Lithium Administration Affects Gene Expression of Thyroid Hormone Receptors in Rat Brain , Life Sciences, 64(20): 1999,1793-1802
Rapaport, M.H., Gyulai, L. Whybrow, P.C. Immune Parameters in Rapid Cycling Bipolar patients Before and After Lithium Treatment , J. Psychiatry Research , 33: 1999,335-340